DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
This application is a domestic application, filed 15 July 2024; claims benefit as a CON of 17/669,982, filed 11 Feb 2022, issued as PAT 12,037,714; and claims benefit as a CON of 16/461,455, which is the national stage entry of PCT/US17/62524, filed 20 Nov 2017, issued as PAT 11,248,314; which claims benefit of provisional application 62/425,323, filed 22 Nov 2016.
Claims 16-34 are pending in the current application and are examined on the merits herein.
Specification
The title of the invention is not descriptive. A new title is required that is clearly indicative of the invention to which the claims are directed.
In this case the claims are directed to a poly alpha-1,3-glucan ester, and not a process for making polyacrylonitrile fibers.
The abstract of the disclosure is objected to because the abstract describes a process for making polyacrylonitrile fibers. A corrected abstract of the disclosure is required and must be presented on a separate sheet, apart from any other text. See MPEP § 608.01(b).
Applicant is reminded of the proper content of an abstract of the disclosure.
In chemical patent abstracts for compounds or compositions, the general nature of the compound or composition should be given as well as its use, e.g., “The compounds are of the class of alkyl benzene sulfonyl ureas, useful as oral anti-diabetics.” Exemplification of a species could be illustrative of members of the class. For processes, the type of reaction, reagents and process conditions should be stated, generally illustrated by a single example unless variations are necessary.
Claim Rejections - 35 USC § 103
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention.
Claims 16-23 and 32-34 are rejected under 35 U.S.C. 103 as being unpatentable over Shibata et al. (US 5,472,599, issued 5 Dec 1995, cited in PTO-892).
Shibata et al. teaches a separation agent essentially comprising an aliphatic or aromatic ester of a polysaccharide (abstract). Examples of the polysaccharide include α-1,3-glucans, and preferred ones are those capable of easily yielding highly pure polysaccharides, such as cellulose, amylose, β-1,4-chitosan, chitin, β-1,4-mannan, β-1,4-xylan, inulin, curdlan and α-1,3-glucan (column 2, lines 1-10), where the alternative of the highly pure α-1,3-glucan addresses limitations of claims 16-18. Shibata et al. teaches working examples of different polysaccharides that are tribenzoyl substituted (columns 11-13) and a dibenzoate xylan (columns 13-14), or a degree of substitution of 3.0 or 2 with the benzoyl group. These polysaccharides have a number-average degree of polymerization (average number of pyranose or furanose rings in the molecule) of at least 5, preferably at least 10. Though there is provided no upper limit of the degree of polymerization, it is preferably 500 or less from the view point of the ease of handling (column 2, line 10-20), addressing limitations of claims 19-22. The resolving agent may be used in membrane resolution method (column 2, line 65). In the membrane resolution process, the resolving agent is used in the form of a hollow filament or film (column 4, line 10), or the form of a fiber or film addressing limitations of claims 33-34.
Shibata et al. does not specifically disclose the embodiment of the composition comprising a poly α-1,3-glucan ester comprising a benzoyl group (claim 16).
Shibata et al. further teaches an object of the present invention is to provide a resolving agent having a chemical structure different from those of known resolving agents, particularly the resolving agents containing cellulose triacetate, as an effective com ponent, and therefore, the resolving characteristics different from those of the known ones or a higher faculty of discriminating and identifying the optical isomers (column 1, lines 50-55). Shibata et al. further teaches in the polysaccharide, the hydroxyl groups other than those forming the linkage bond with the above-mentioned carboxylic acid may be present in the form of free hydroxyl groups or they may be esterified, etherified or carbamoylated so far as the resolving ability of the resolving agent is not damaged (column 2, lines 30-35). Shibata et al. further teaches working examples of polysaccharides having acetyl group substituents, such as β-1,4-mannan triacetate (column 7), chitin diacetate (column 9), and amylose triacetate (column 10).
It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to select from within the teachings of Shibata et al. to arrive at the tribenzoyl or dibenzoyl α-1,3-glucan. One of ordinary skill in the art would have been motivated to select from within the teachings of Shibata et al. with a reasonable expectation of success because Shibata et al. teaches a preferred polysaccharide is the highly pure α-1,3-glucan, and teaches working examples of different polysaccharides that are tribenzoyl substituted as well as a dibenzoyl substituted xylan, suggesting it would have been obvious to select the tribenzoyl or dibenzoyl α-1,3-glucan ester. Regarding claims 16-18 reciting the amount of α-1,3-glycosidic linkages, Shibata et al. teaches highly pure α-1,3-glucan is preferred, providing guidance for selecting the polysaccharide to pure α-1,3-glucan or having only α-1,3-glycosidic linkages. Regarding claims 19-22 reciting the weight-average degree of polymerization, MPEP 2144.05 at I. provides “In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990)” In this case Shibata et al. teaches the number-average degree of polymerization is preferably at least 10 and preferably 500 or less, making obvious the overlapping range for the degree of polymerization of the polysaccharide. Taken as a whole, for the reasoning detailed above Shibata et al. makes obvious the pure α-1,3-glucan that tribenzoyl or dibenzoyl substituted, which would have the chemical structure shown in claim 23 where 2 or 3 of R is a benzoyl group and any remaining R is H, and n is between 10 and 500. Regarding claim 32, Shibata et al. teaches working examples of polysaccharides having benzoate or acetate substitution, suggests that hydroxyl groups other than the ones modified by the specific carboxylic acid substitution many be further esterified, and teaches it is desired to provide a resolving agent having a chemical structure different from known resolving agents, particularly cellulose triacetate, suggesting it would have been obvious to combine both benzoate and acetate substitution with a reasonable expectation of success.
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 16-18, 24-31 and 33 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-13 of U.S. Patent No. 12,037,714.
Although the claims at issue are not identical, they are not patentably distinct from each other because Reference claims 1-10 are drawn to a process which produces a polysaccharide ester product, wherein the polysaccharide comprises poly alpha-1,3-glucan, wherein at least 50% of the glycosidic linkages of the poly alpha-1,3-glucan are alpha-1,3 glycosidic linkages, and wherein the polysaccharide ester product has a degree of substitution of about 0.001 to about 3.0. Reference claim 6 recites the ester comprises a benzoyl group, addressing limitations of claim 16. Reference claims 2-3 recite at least 90% or 99% of the glycosidic linkages of the poly alpha-1,3-glucan are alpha-1,3 glycosidic linkages, addressing limitations of claims 17-18. Reference claim 4 recites polysaccharide ester product has a degree of substitution of about 0.3 to about 1.5, addressing claims 24-25. Reference claims 11-13 are drawn to fibers prepared by the process of reference claim 1, particularly claimed the product itself and addressing limitations of claim 33.
It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of Reference claims 1-13 in order to make obvious possession of the composition comprising the poly alpha-1,3-glucan ester. One of ordinary skill in the art would have been motivated to combine the teachings of Reference claims 1-13 with a reasonable expectation of success because claims 1-10 are drawn to a process which produces a polysaccharide ester product, making obvious possession of the product so produced, and provides guidance for the ester to be a benzoyl ester, and guidance for selecting the degree of substitution. Regarding the specific degree of substitution of claims 26-31, MPEP 2144.05 at I. provides “In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990)” In this case Reference claims 1 and 4 suggest it would have been obvious to select the degree of substitution from within disclosed ranges. Further, Reference claims 11-13 are drawn to fibers prepared by the process of reference claim 1, making obvious possession of the product so produced.
Claims 16-18, 24-31 and 33 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-16 of U.S. Patent No. 11,248,314.
Although the claims at issue are not identical, they are not patentably distinct from each other because Reference claims 1-10 and 15-16 are drawn to a process which produces a polysaccharide ester product which combined with a polyacrylonitrile to form a blend, wherein the polysaccharide comprises poly alpha-1,3-glucan, wherein at least 50% of the glycosidic linkages of the poly alpha-1,3-glucan are alpha-1,3 glycosidic linkages, and wherein the polysaccharide ester product has a degree of substitution of about 0.001 to about 3.0. Reference claim 8 recites the ester produced with an acyl halide encompassing benzoyl chloride, benzoyl bromide, and benzoyl iodide, addressing limitations of claim 16 wherein the ester comprises a benzoyl group. Reference claims 5 and 9 recite at least 90% or 99% of the glycosidic linkages of the poly alpha-1,3-glucan are alpha-1,3 glycosidic linkages, addressing limitations of claims 17-18. Reference claim 10 and 13 recites polysaccharide ester product has a degree of substitution of about 0.3 to about 1.5, addressing claims 24-25. Reference claims 11-14 are drawn to fibers prepared by the process of reference claim 1, particularly claimed the product itself and addressing limitations of claim 33.
It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of Reference claims 1-16 in order to make obvious possession of the composition comprising the poly alpha-1,3-glucan ester. One of ordinary skill in the art would have been motivated to combine the teachings of Reference claims 1-16 with a reasonable expectation of success because claims 1-10 and 15-16 are drawn to a process which produces a polysaccharide ester product, making obvious possession of the product so produced, and provides guidance for the ester to be a benzoyl ester, and guidance for selecting the degree of substitution. Regarding the specific degree of substitution of claims 26-31, MPEP 2144.05 at I. provides “In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990)” In this case Reference claims 1 and 10 suggest it would have been obvious to select the degree of substitution from within disclosed ranges. Further, while Reference claims 1-10 and 15-16 are drawn to the method, Reference claims 11-14 are drawn to fibers prepared by the process of reference claim 1, making obvious possession of the product produced by the claimed method. Regarding the Reference product comprising a blend of the polysaccharide ester product which combined with a polyacrylonitrile, the composition of the examined claims recites the composition using the open transitional phrase “comprising”, therefore the composition of the examined claims is open to encompassing the poly alpha-1,3-glucan ester in combination with other unlisted components such as a polyacrylonitrile.
Conclusion
No claim is currently in condition for allowance.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Jonathan S Lau whose telephone number is (571)270-3531. The examiner can normally be reached Monday-Friday 9a-5p Eastern.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at (571)270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JONATHAN S LAU/ Primary Examiner, Art Unit 1693